Herpes zoster vaccine (Zostavax®): Cellulitic injection site reaction or bacterial cellulitis?
A 70 y old woman presented with a cellulitic reaction following Zostavax® injection. This reaction could be differentiated from bacterial cellulitis on the basis of the temporal relationship between vaccination and onset of the reaction, its non progression and unresponsiveness to antibiotic therapy...
Saved in:
Main Author: | Ian F. Cook (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015
by: Elaine R. Miller, et al.
Published: (2018) -
Herpes zoster vaccination. An update
by: Khairuddin Djawad, et al.
Published: (2022) -
Herpes Zoster
by: Hamid Ehsani-Nia, et al.
Published: (2017) -
Vaccine-Associated Herpes Zoster Ophthalmicus and Encephalitis
by: J Gordon Millichap
Published: (2010) -
Vaccine profile of herpes zoster (HZ/su) subunit vaccine
by: Anthony L. Cunningham, et al.
Published: (2017)